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Yafei Guo and Syuzanna R. Harutyunyan*
Abstract: General methods to prepare chiral N-heterocyclic
molecular scaffolds are greatly sought after because of their
significance in medicinal chemistry. Described here is the first
general catalytic methodology to access a wide variety of chiral
2- and 4-substituted tetrahydro-quinolones, dihydro-4-pyri-
dones, and piperidones with excellent yields and enantioselec-
tivities, utilizing a single catalyst system.
Optically active piperidine and tetrahydroquinoline deriv-
atives are ubiquitous structural motifs in alkaloid-based
natural products, and bioactive and pharmaceutical com-
pounds. Some examples to be highlighted include Torcetrapib,
a drug used to treat elevated cholesterol levels, the antibiotic
Helquinoline, as well as various alkaloids such as the
Angustureine, Coniine, Myrtine, Solenopsin series and Indo-
lizidine (Scheme 1A).[1] Accordingly, chiral piperidine and
tetrahydroquinoline derivatives represent important syn-
thetic targets. General asymmetric synthetic routes for their
synthesis rely on several strategic approaches (Scheme 1B).
Some of the most developed routes to chiral substituted
tetrahydroquinolines make use of catalytic asymmetric
hydrogenation of quinoline derivatives using chiral transi-
tion-metal complexes and transfer hydrogenations by chiral
Brønsted acids with Hantzsch esters.[2] Efficient catalytic
asymmetric synthesis to access chiral hydroquinoline, quino-
lone, and piperidone derivatives using intramolecular aza-
Michael and aza-Diels–Alder reactions, catalyzed by Lewis or
Brønsted acids, have been also explored.[3]
Other potential alternative N-heterocyclic precursors for
the synthesis of chiral piperidine and tetrahydroquinoline
derivatives include piperidones, dihydropyridones, and qui-
nolones, which in addition are often found as part of more
complex biologically active compounds.[4]A common strategy
for accessing these precursors is the asymmetric conjugate
addition of organometallics to N-heterocyclic acceptors using
chiral auxiliaries.[5] However, catalytic enantioselective meth-
odologies for conjugate additions to, for example quinolone,
pyridone, dihydropyridone, and acylpyridinium salts, would
constitute more attractive routes. Several such methods for
additions of organometallics to 4-quinolones and dihydropyr-
idone have been developed to date, with the most successful
examples focusing on arylations.[6] In contrast, for asymmetric
alkylations there are only a few reports which make use of
dihydropyridone[6f,g] and an acylpyridinium salt.[1a,7, 8b] These
alkylation methods suffer from limited product scope with
either low yields or moderate enantioselectivities. Further-
more, catalytic asymmetric alkylation of 4-quinolones and
catalytic asymmetric conjugate additions, in general, to
2-quinolones as well as 4-pyridone[8] are unknown. In pursuit
Scheme 1. A) Examples of pharmaceuticals and natural products fea-
turing chiral an N-heterocyclic core. B) State of the art. C) This work.
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of a catalytic asymmetric approach to a wide variety of chiral
N-heterocyclic compounds we were interested in developing
a single catalytic system capable of harnessing the reactivity
of various N-heterocyclic acceptors.
Herein, we describe the first general protocol for catalytic
asymmetric addition of various Grignard reagents to a wide
variety of N-heterocyclic acceptors with excellent yields and
enantioselectivities (Scheme 1C), and it requires a single
catalytic system based on a copper salt and chiral diphosphine
ligand.
Our initial studies focused on the development of an
efficient catalytic methodology for the alkylation of
4-quinolones (Table 1). To compensate for the relatively low
reactivity of the 4-quinolone acceptor, we decided to take
advantage of the high reactivity of Grignard reagents. For the
screening of catalytic systems and reaction conditions we
chose the addition of EtMgBr to the carboxybenzyl-protected
(Cbz) 4-quinolone 1a as a model reaction. Addition of
EtMgBr in the absence of any catalyst did not provide
substrate conversion, even at room temperature (entry 1).
First we set out to identify promising chiral catalysts, using
5 mol% of CuBr·SMe2 and 6 mol% of various chiral
diphoshine (L1–L5) and phosphoarmidite (L6) ligands. To
our delight, using the chiral diphosphine ligand L1, developed
by Pilkington et al.,[9] the reaction proceeded to completion in
12 hours at @78 8C, providing the isolated final product 2a in
99% yield and with 99% of enantiomeric excess. Optimiza-
tion of the reaction temperature (entries 2–5) allowed us to
establish highly practical conditions in which the addition
product can be obtained at room temperature in only 20–
30 minutes with a yield and enantiomeric purity of 98%
(entry 5). This result is remarkable in its own right, as it
represents the first example of highly enantioselective
catalytic conjugate addition of Grignard reagents at room
temperature.[10] Further ligand screening revealed that neither
of the other diphosphine-type ligands (L2--L5) nor the
phosphoramidite-type ligand L6 work for this chemistry
both in terms of yield and enantioselectivity (entries 6–10).
This discovery is rather surprising, as all of these ligands are
normally very efficient in Grignard additions to more
conventional Michael acceptors.[11]
Based on these results we adopted the following opti-
mized reaction conditions for further substrate scope studies:
CuBr·SMe2 (5 mol%), (R,R)-L1 (6 mol%), and Grignard
reagent (2.0 equiv) in CH2Cl2 for 30 minutes at room temper-
ature.
Next, we evaluated EtMgBr with quinolones featuring
various substituents at the N atom (Scheme 2). We found that
quinolones with electron-withdrawing groups such as Cbz and
Boc are well tolerated and give the corresponding products
(2a and 2b) with excellent yields and enantiomeric excess.
However, for less-reactive Bn- and Me-protected quinolones
the addition products 2c and 2d can only be isolated in the
presence of a Lewis acid (TMSBr) with good yields and
moderate 42–43% ee. Importantly, the addition of EtMgBr to
the unprotected quinolone substrate in the presence of
TMSBr provided the corresponding product 2e with 52%
yield and 96% ee.
Having established the effect of the substituents at the
nitrogen atom of the quinolone we explored the scope of
Grignard reagents with 1a (Scheme 2). We were pleased to
find that our catalytic system enables the addition of a wide
variety of alkyl Grignard reagents, including linear, a-, b-, and
g-substituted reagents, as well as functionalized PhMgBr and
pTolMgBr, providing products (2 f–n) all with excellent
results. This scope even extended to the markedly less
reactive MeMgBr, for which 2o was obtained with 93%
yield and 97% enantiomeric excess.
Subsequently we examined the scope with respect to the
N-Cbz-4-quinolone substrates and found that substrates
bearing functional groups such as Me, Br, CF3, ether, amide,
or ester at the 5, 6, and 7-positions, were all converted into the
corresponding final products (2p–v) successfully (Scheme 2).
In all cases, our optimized system afforded the products in
excellent yields (66% to 99%) and enantioselectivities (ees
94% to 99%). However, when 2-Me-N-Cbz-4-quinolone was
used as a substrate, a lack of reactivity prevented the
formation of the addition product 2w with a quaternary
stereocenter.
To expand this strategy towards the synthesis of chiral
dihydro-pyridones and piperidones, we hypothesised that this
Table 1: Optimization of reaction conditions for the addition of EtMgBr
to N-Cbz-4-quinolone (1a).[a]
Entry T [8C] t [h] Ligand Yield [%][b] ee [%][c]
1[d] RT 2 – 0 0
2 @78 12 L1 99 99
3 @20 2 L1 99 99
4 0 2 L1 99 98
5 RT 0.5 L1 98 98
6 RT 0.5 L2 21 28
7 RT 0.5 L3 78 27
8 RT 0.5 L4 82 57
9 RT 0.5 L5 32 0
10 RT 0.5 L6 71 0
[a] Reaction conditions: N-Cbz-4-quinolone 1a (0.2 mmol), EtMgBr
(2.0 equiv), L (6 mol%), and CuBr·SMe2 (5 mol%) in CH2Cl2 (2 mL).
[b] Yields are those for the isolated products. [c] The enantiomeric excess
was determined by HPLC on a chiral stationary phase. [d] Reaction
without CuBr·SMe2 and ligand.
Angewandte
ChemieCommunications
12951Angew. Chem. Int. Ed. 2019, 58, 12950 –12954 T 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.angewandte.org
protocol could also enable addition reactions to N-Cbz-4-
pyridone (3 ; Scheme 3). This substrate is more challenging for
applications in catalysis as its aromatic character reduces the
reactivity towards nucleophilic additions. As a result, pyr-
idones have been hardly explored in asymmetric catalysis,[8]
even though there is major potential in the application of
these substrates in chemical synthesis: after the initial
conjugate addition reaction the resulting chiral N-heterocy-
clic product, with remaining Michael acceptor functionality,
can subsequently undergo further stereoselective functional-
izations to provide 2,6-substituted chiral pyridines, which can
be useful for natural product synthesis. We initially evaluated
the reactivity of 3 towards nucleophilic addition of EtMgBr
using the reaction conditions optimized for N-Cbz-4-quino-
lones (Table 1, entry 2). Unfortunately the corresponding
addition product 4a was not obtained, but instead the side
products derived from the addition of EtMgBr to the
carboxybenzyl moiety were found.[12] To steer the chemo-
selectivity of the reaction towards 4a, we decided to introduce
Lewis acids.[8a,b] With BF3·OEt2 as the Lewis acid the best
possible results, with 95% yield and more than 99%
enantiomeric purity, were obtained (Scheme 3).[13] With
these reaction conditions we assessed the scope with respect
to the organomagnesium reagents for this reaction system. A
number of chiral 2-substituted 2,3-dihydro-4-pyridone prod-
ucts derived from the addition of linear (4a–d), b-, and g-
branched (4e,f) and functionalized (4g–i) Grignard reagents
were synthesized with high yields. In all cases excellent
enantioselectivities were observed as well (ee values 94 to
> 99%).
Although asymmetric conjugate addition of arylboronic
acid, and aryl and dialkylzinc nucleophiles to N-substituted-
2,3-dihydro-4-pyridones has been well explored in recent
years[5, 6f,g] we were interested in investigating the behavior of
our catalytic system when applied to these substrates. Given
their substantially higher reactivity than 3 we anticipated that
Lewis acids would not be needed and that low temperatures
would most likely be required to avoid noncatalyzed addition
of Grignard reagents. Indeed, quick screening of several
Grignard reagents, namely MeMgBr, EtMgBr, and nPrMgBr
supported this notion and the corresponding chiral 2-sub-
stituted 4-piperidones (6a–c) were obtained with excellent
yields and enantiomeric excesses above 90% (Scheme 4).
Our next quest was to access chiral products derived from
additions to N-substituted-2-quinolones, which are formally
cyclic a,b-conjugated amides and are expected to be less
reactive than 4-quinolones (Scheme 5). We were pleased to
find that when using 2-quinolones with an OMe protecting
group at the N atom, the corresponding deprotected products
8a–h were obtained with excellent enantiomeric excess and
chemical yields. However, to reach full conversion and high
Scheme 2. Scope of the reaction between the N-Cbz-4-quinolone
substrates 1 and organomagnesium reagents. Reaction conditions: N-
Cbz-4-quinolones 1 (0.2 mmol), EtMgBr (2.0 equiv), L1 (6 mol%), and
CuBr·SMe2 (5 mol%) in CH2Cl2 (2 mL) at room temperature for 0.5 h.
[a] Reactions with the quinolones 1c–e were carried out in the
presence of TMSBr (2.0 equiv) at @78 8C for 12 h. Absolute configu-
ration of 2k was established by X-ray crystallography.[14] [b] PhMgBr
and pTolMgBr were added slowly by a syringe pump in 2 h at 0 8C.
Scheme 3. Scope of the reaction of N-Cbz-4-pyridone (3) with organo-
magnesium reagents. Reaction conditions: 3 (0.2 mmol), Grignard
reagents (2.0 equiv), L1 (6 mol%), BF3·OEt2 (2.0 equiv), and
CuBr·SMe2 (5 mol%) in CH2Cl2 (2 mL) at @78 8C for 12 h.
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yields it is necessary to use a Lewis acid, with TMSBr
performing best. Importantly, the methoxy substituent at the
N atom is removed upon reaction work up. Using this
reaction protocol we obtained a variety of products using
various Grignard reagents as well as substrates with different
substituents in the aromatic ring. It is noteworthy that this
catalytic system tolerates 2-quinolone substrates with various
protecting groups, such as Me, Bn, and allyl on N. The
products 8 i–k, derived from conjugate addition of EtMgBr to
these substrates, were obtained with enantiomeric purities
above 93% and yields above 72%.
Finally, to demonstrate the potential applications of our
reaction protocol, we carried out a gram-scale reaction as well
as several additional transformations, all depicted in
Scheme 6.
In summary, we have developed the first general protocol
for the alkylation of various classes of N-heterocyclic electro-
philes with organomagnesium reagents, utilizing one catalytic
system based on a CuI complex with (R,R)-Ph-BPE. Alkyla-
tion of 2-quinolones, 4-quinolones, and 4-pyridones provides
easy access to various derivatives of chiral 2- and 4-substituted
tetrahydroquinolones and dihydro-4-pyridones in excellent
yields and enantioselectivities. Significantly, addition reac-
tions to N-substituted-4-quinolones can be carried out at
room temperature, while consecutive alkylation of pyridone
and the resulting 2,3-dihydro-4-pyridones allows convenient
catalytic access to 2,6-substituted diastereomerically and
enantiomerically pure piperidones. We anticipate that this
methodology will be a valuable synthetic tool and find
practical application in the synthesis of complex building
blocks and natural and pharmaceutical compounds.
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Scheme 4. Scope of the reaction of N-Cbz-2,3-dihydro-4-pyridone (5)
with organomagnesium reagents. Reaction conditions: N-Cbz-2,3-
dihydro-4-pyridone 5 (0.2 mmol), EtMgBr (2.0 equiv), L1 (6 mol%),
and CuBr·SMe2 (5 mol%) in CH2Cl2 (2 mL) at @78 8C for 12 h.
Scheme 5. Scope of conjugate addition reactions of organomagnesium
reagents to the N-protected 2-quinolones 7. Reaction conditions:
2-quinolone 7 (0.2 mmol), EtMgBr (2.0 equiv), Ligand L1 (6 mol%),
TMSBr (2.0 equiv), and CuBr·SMe2 (5 mol%) in CH2Cl2 (2 mL) at
@78 8C for 12 h. Absolute configuration of 8 j was established by X-ray
crystallography.[14]
Scheme 6. Gram-scale reaction and useful derivatizations.
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